IceCure Medical (ICCM) Accumulated Depreciation & Amortization (2020 - 2025)
IceCure Medical (ICCM) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $1.6 million as the latest value for Q4 2024.
- On a quarterly basis, Accumulated Depreciation & Amortization rose 27.24% to $1.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.6 million, a 27.24% increase, with the full-year FY2024 number at $1.6 million, up 27.24% from a year prior.
- Accumulated Depreciation & Amortization was $1.6 million for Q4 2024 at IceCure Medical, up from $1.2 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.6 million in Q4 2024 to a low of $63000.0 in Q4 2020.
- A 5-year average of $641600.0 and a median of $248000.0 in 2022 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 391.53% in 2023, then grew 27.24% in 2024.
- IceCure Medical's Accumulated Depreciation & Amortization stood at $63000.0 in 2020, then skyrocketed by 101.59% to $127000.0 in 2021, then surged by 95.28% to $248000.0 in 2022, then surged by 391.53% to $1.2 million in 2023, then increased by 27.24% to $1.6 million in 2024.
- Per Business Quant, the three most recent readings for ICCM's Accumulated Depreciation & Amortization are $1.6 million (Q4 2024), $1.2 million (Q4 2023), and $248000.0 (Q4 2022).